The heat shock protein profile in children with chronic kidney disease

Kinga Musial1, Krystyna Szprynger, Maria Szczepańska

  • 1Department of Pediatric Nephrology, Medical University, Wroclaw, Poland.

Insights

Children with chronic kidney disease (CKD) show altered heat shock proteins (HSPs) and antibodies, suggesting disturbed stress responses and potential roles as atherosclerosis markers.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Research
  • Immunology

Background:

  • Chronic kidney disease (CKD) in children is linked to inflammation, lipid disorders, and endothelial dysfunction, increasing atherosclerosis risk.
  • Elevated heat shock proteins (HSPs) and anti-HSP antibodies are associated with atherosclerosis in adults, but their role in pediatric CKD is unexplored.

Purpose of the Study:

  • To investigate the profile of HSPs and their antibodies in children with CKD.
  • To assess the potential role of HSPs as atherosclerosis markers in pediatric CKD patients.

Main Methods:

  • Studied 37 children with conservative CKD, 19 on automated peritoneal dialysis (APD), and 15 healthy controls.
  • Measured serum concentrations of HSP-60, HSP-70, HSP-90alpha, anti-HSP-60, anti-HSP-70, sE-selectin, IL-4, and hs-CRP.
  • Assessed serum lipid profiles (total cholesterol, HDL, LDL, triglycerides).

Main Results:

  • HSP-90alpha, anti-HSP-60, and sE-selectin were elevated in CKD and APD patients compared to controls.
  • Anti-HSP-70 levels were higher in CKD patients than controls; IL-4 was increased in all patient groups.
  • HSP-60 levels were decreased in CKD and APD children, while HSP-70 and hs-CRP were similar across groups.

Conclusions:

  • Altered HSP and anti-HSP concentrations suggest disturbed stress responses in pediatric CKD, not significantly worsened by APD.
  • Relationships between HSPs, lipids, and inflammation markers indicate HSPs may serve as atherosclerosis markers in children with CKD.
Abstract

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...